“Reaching a project goal requires foresight, patience, and hard work, but with focus and a wonderful team full of energy and mutual respect, we achieve every goal successfully and with great jointly satisfaction.”
During studying Biology at the Justus-Liebig University in Giessen, Dr. Andreas Berk had his first insights of clinical development while characterizing a potential investigational drug during pre-clinical investigations as part of his dissertation.
Thereafter he learned clinical research from the basis when he went through different CRA stages during three years in world largest Contract Research Organization. After first project management steps in Biosimilar area he enhanced his project management knowledge by leading large national and international trials in various indications with investigational drugs during his employ ship at ClinTriCare GmbH & Co. KG.
With the beginning of his work for Innovation Triologie GmbH & Co. KG, he additionally supported a CRO with developing and maintaining of the SOP landscape, but also was regularly consulted by Pharma companies and Investigators to support in various areas of their clinical development programs from outsourcing support and strategic setting the course to inspection readiness tasks and risk management.
Since July 1, 2024 he is promoted as Chief Operating Officer and Managing Director for InnovationTriologie.